Table 1 Clinical and demographic characteristics of the myeloma patients at the first dental examination (n = 144)
Age, year median (range) | 76 (49–93) |
Gender n (%) | |
Male | 96 (66.7) |
Female | 48 (33.3) |
Comorbidity n (%) | |
Adult comorbidity evaluation −27, median (range) | 1.5 (0–3) |
3 | 18 (12.5) |
2 | 55 (38.2) |
1 | 55 (38.2) |
0 | 16 (11.1) |
Number of antineoplastic treatments, median (range) | 2 (0–7) |
Patients undergoing HSCT1 n (%) | 28 (19.4) |
Follow-up time, months (range) | 22.5 (1–92) |
Dental status | |
Number of teeth, median (range) | 24 (0–28) |
Edentulous patients n (%) | 4 (2.8) |
DMFT2, median (range) | 21 (4–28) |
Decayed teeth, median (range) | 0 (0–9) |
Missed teeth, median (range) | 4 (0–28) |
Filled teeth, median (range) | 14 (0–23) |
Periodontal status n (% of patients) | |
No periodontitis | 61 (42.3) |
Slight periodontitis | 48 (33.3) |
Moderate periodontitis | 26 (18.1) |
Severe periodontitis | 9 (6.3) |
Periapical status n (% of patients) | |
Periapical lesion (%) | 48 (33.3) |
Applied treatment prior to BP3 n (% of patients) | |
Tooth extraction n (%) | 48 (33.3) |
Root canal treatment n (%) | 8 (5.6) |
Removable prosthetics n (% of patients) | 22 (15.3) |